Non-Small Cell Lung Cancer - Pipeline Review, H1 2017; New Report Launched
Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H1 2017, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.
View full press release